These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 7813389)
41. Methodology of a controlled clinical study for cerebral aging evaluation. Vecchi GP; Neri M; Cortelloni C; De Vreese L; Sirotti C; Cipolli C; Fabbri L; Zerbini O Int J Clin Pharmacol Res; 1990; 10(1-2):145-52. PubMed ID: 2201654 [TBL] [Abstract][Full Text] [Related]
42. A clinical and neurophysiological trial on nootropic drugs in patients with mental decline. Gallai V; Mazzotta G; Del Gatto F; Montesi S; Mazzetti A; Dominici P; Della Monica A Acta Neurol (Napoli); 1991 Feb; 13(1):1-12. PubMed ID: 1867125 [TBL] [Abstract][Full Text] [Related]
43. [Duxil and cognitive deficiency in the elderly. Results of a 6-month controlled multicenter study]. Poitrenaud J; Piette F; Malbezin M; Sebban C; Guez D Ann Med Interne (Paris); 1990; 141 Suppl 1():31-5. PubMed ID: 2082783 [TBL] [Abstract][Full Text] [Related]
44. L-Acetylcarnitine in dysthymic disorder in elderly patients: a double-blind, multicenter, controlled randomized study vs. fluoxetine. Bersani G; Meco G; Denaro A; Liberati D; Colletti C; Nicolai R; Bersani FS; Koverech A Eur Neuropsychopharmacol; 2013 Oct; 23(10):1219-25. PubMed ID: 23428336 [TBL] [Abstract][Full Text] [Related]
45. Effects of acetyl-L-carnitine on reaction times in patients with cerebrovascular insufficiency. Arrigo A; Casale R; Buonocore M; Ciano C Int J Clin Pharmacol Res; 1990; 10(1-2):133-7. PubMed ID: 2387660 [TBL] [Abstract][Full Text] [Related]
46. Efficacy of music therapy treatment based on cycles of sessions: a randomised controlled trial. Raglio A; Bellelli G; Traficante D; Gianotti M; Ubezio MC; Gentile S; Villani D; Trabucchi M Aging Ment Health; 2010 Nov; 14(8):900-4. PubMed ID: 21069596 [TBL] [Abstract][Full Text] [Related]
47. L-acetylcarnitine as a new therapeutic approach for peripheral neuropathies with pain. Onofrj M; Fulgente T; Melchionda D; Marchionni A; Tomasello F; Salpietro FM; Alafaci C; De Sanctis E; Pennisi G; Bella R Int J Clin Pharmacol Res; 1995; 15(1):9-15. PubMed ID: 7490173 [TBL] [Abstract][Full Text] [Related]
48. Pharmaco-electroencephalographic and clinical effects of the cholinergic substance--acetyl-L-carnitine--in patients with organic brain syndrome. Herrmann WM; Dietrich B; Hiersemenzel R Int J Clin Pharmacol Res; 1990; 10(1-2):81-4. PubMed ID: 2201660 [TBL] [Abstract][Full Text] [Related]
49. Evaluation of the efficacy of animal-assisted therapy based on the reality orientation therapy protocol in Alzheimer's disease patients: a pilot study. Menna LF; Santaniello A; Gerardi F; Di Maggio A; Milan G Psychogeriatrics; 2016 Jul; 16(4):240-6. PubMed ID: 26370064 [TBL] [Abstract][Full Text] [Related]
50. Neurophysiological studies of L-acetylcarnitine administration in man. Gambi D; Onofrj M; Calvani M; Faricelli A; Del Re ML; Bazzano S; Cutarella R; Fulgente T; Colangelo U Drugs Exp Clin Res; 1989; 15(9):435-46. PubMed ID: 2630254 [TBL] [Abstract][Full Text] [Related]
51. Central nervous system stimulants as symptomatic treatments for AIDS-related neuropsychiatric impairment. Angrist B; d'Hollosy M; Sanfilipo M; Satriano J; Diamond G; Simberkoff M; Weinreb H J Clin Psychopharmacol; 1992 Aug; 12(4):268-72. PubMed ID: 1527230 [TBL] [Abstract][Full Text] [Related]
52. [Psycho-functional changes in attention and learning under the action of L-acetylcarnitine in 17 young subjects. A pilot study of its use in mental deterioration]. Lino A; Boccia MM; Rusconi AC; Bellomonte L; Cocuroccia B Clin Ter; 1992 Jun; 140(6):569-73. PubMed ID: 1638856 [TBL] [Abstract][Full Text] [Related]
53. [A controlled clinical study on the efficacy of L-acetylcarnitine in the treatment of mild-to-moderate mental deterioration in the aged. Conclusions]. Genazzani E Clin Ter; 1990 Mar; 132(6 Suppl):511-2. PubMed ID: 2140974 [No Abstract] [Full Text] [Related]
54. [Psychological studies of a long-term treatment of the neurovascular syndrom with Trivastal (author's tranls)]. Scholing WE; Clausen HD Med Klin; 1975 Sep; 70(38):1522-7. PubMed ID: 1102887 [TBL] [Abstract][Full Text] [Related]
55. [Clinical development of a drug for brain aging. Current limitations and future prospects]. Zerbini O; Recchia G; Fabbri L Clin Ter; 1990 Mar; 132(6 Suppl):451-5. PubMed ID: 2140969 [TBL] [Abstract][Full Text] [Related]
56. [Methodological premises of statistical analysis of the data]. Bamfi F; Girelli M Clin Ter; 1990 Mar; 132(6 Suppl):475-8. PubMed ID: 2140972 [TBL] [Abstract][Full Text] [Related]
57. Short-Term Impact of a Combined Nutraceutical on Cognitive Function, Perceived Stress and Depression in Young Elderly with Cognitive Impairment: A Pilot, Double-Blind, Randomized Clinical Trial. Cicero AF; Bove M; Colletti A; Rizzo M; Fogacci F; Giovannini M; Borghi C J Prev Alzheimers Dis; 2017; 4(1):12-15. PubMed ID: 29188854 [TBL] [Abstract][Full Text] [Related]
58. [Evaluation of pharmacologic treatment associated with motor-activation therapy in the prevention of senile impairment]. Belloi L; Pirani A; Bongiorno G; Melloni M; Dinelli M; Francia R; Gallerani A; Vecchi GP Minerva Med; 1987 Oct; 78(20):1543-50. PubMed ID: 3670697 [TBL] [Abstract][Full Text] [Related]
59. Almitrine-raubasine and cognitive impairment in the elderly: results of a 6-month controlled multicenter study. Poitrenaud J; Piette F; Malbezin M; Sebban C; Guez D Clin Neuropharmacol; 1990; 13 Suppl 3():S100-8. PubMed ID: 2093414 [TBL] [Abstract][Full Text] [Related]